Document Detail

Cardiovascular collapse during ethanol sclerotherapy in a pediatric patient.
MedLine Citation:
PMID:  16490104     Owner:  NLM     Status:  MEDLINE    
Ethanol sclerotherapy is a first line management therapy for low flow vascular malformations. It is usually performed under general anesthesia because of the pain associated with ethanol injection. Ethanol sclerotherapy frequently produces minor local complications but may rarely produce catastrophic cardiopulmonary complications. This report describes the cardiovascular collapse associated with an ethanol sclerotherapy procedure in an 11-year- old child. The evidence for ethanol-induced cardiovascular derangements is discussed.
G A Wong; D C Armstrong; J M Robertson
Related Documents :
14268954 - On the concentration gradient across a spherical source washed by slow flow.
18521804 - Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients...
1605884 - Breath acetaldehyde following ethanol consumption.
6685304 - Zonal redox changes as a cause of selective perivenular hepatotoxicity of alcohol.
23253864 - Infantile pyknocytosis: an under-recognized form of neonatal hemolytic anemia?
7695164 - Procoagulant properties of atherosclerotic aortas.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Paediatric anaesthesia     Volume:  16     ISSN:  1155-5645     ISO Abbreviation:  Paediatr Anaesth     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2006-02-21     Completed Date:  2006-08-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9206575     Medline TA:  Paediatr Anaesth     Country:  France    
Other Details:
Languages:  eng     Pagination:  343-6     Citation Subset:  IM    
Department of Anesthesia, Hospital for Sick Children, Toronto, ON, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anesthesia, General
Ethanol / adverse effects*
Klippel-Trenaunay-Weber Syndrome / complications*
Leg / blood supply*
Sclerosing Solutions / adverse effects*
Sclerotherapy / adverse effects*
Shock / etiology*
Veins / abnormalities*
Reg. No./Substance:
0/Sclerosing Solutions; 64-17-5/Ethanol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Use of dexmedetomidine in awake craniotomy in adolescents: report of two cases.
Next Document:  Menopausal symptoms in Hispanic women and the role of socioeconomic factors.